Ebos cornerstone shareholder sells $323m stake
Shareholder commits to sell no more shares until after full year result.
NBR staff
Tue, 23 Jun 2020
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
The biggest shareholder of medical products distributor Ebos Group has announced a further sell-down of its stake through a bookbuild run by Citigroup.
The process will sell 15 million Ebos shares held by Sybos Holdings at an underwritten price of $21.52, raising $322.8 million.
Ebos shares
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
NBR staff
Tue, 23 Jun 2020
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
